RxDoctor Payments Data

David Galli

Internal Medicine · Chesterfield, MONPI 1255323374

Payments from drug & device makers

What this record shows

26 manufacturers reported payments, led by Sekisui Diagnostics LLC at 54.1% of the total. Reporting peaked in 2022 at $695 and has fallen 61.2% since, to $270 in 2025.

$2,423in general payments, 2019–2025

Across 74 payments — averaging $32.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sekisui Diagnostics LLC$1K
  • AbbVie$176
  • Johnson & Johnson$170
  • Novo Nordisk$106
  • Pfizer$98
  • AstraZeneca$89
  • plus $474 from 20 others

What the payments were for

  • Food & beverage$1,11346%
  • Gifts$1,31054%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,423 in reported general payments places this provider in the 80th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium13$96
Amlodipine Besylate18$45

Paid to pharmacies, not to this prescriber.

Other internal medicine in Chesterfield

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →